GRG's Center For Experiential Learning

Systemic Sclerosis care is entering a new era of clinical innovation. This blog explores how recent advances in treatment and disease understanding are improving outcomes, enhancing patient quality of life, and reshaping how clinicians approach this complex autoimmune condition.

Managing Hypophosphatasia (HPP) continues to challenge physicians and patients alike, from delayed diagnoses and limited treatment options to gaps in awareness and collaboration. Through in-depth conversations with specialists across Canada, GRG Health uncovers the realities shaping HPP care in 2025 and the urgent need for education, teamwork, and faster insights to drive real change.

Metastatic melanoma was once a near-certain death sentence, but PD-1/PD-L1 inhibitors have rewritten the story. From survival rates once measured in months to long-term remission and renewed hope, immune checkpoint therapies like nivolumab and pembrolizumab are transforming cancer care and reshaping the future of oncology.

Emerging therapies like complement and FcRn inhibitors are reshaping Myasthenia Gravis care, offering more targeted and effective options for patients. But with challenges in diagnosis, access, and long-term safety still in play, the road ahead demands innovation, collaboration, and a patient-centered approach.

Discover how Cryoneurolysis is transforming pain management, offering targeted, drug-free, non-surgical relief for chronic and post-operative pain, with minimal downtime and lasting results.

The U.S. generic injectables market is expanding fast but so are drug shortages. Based on insights from 300 pharmacy directors, this blog unpacks the real issues behind the supply strain and what healthcare leaders say needs to change.